Format

Send to

Choose Destination
JAMA. 2019 May 28;321(20):2025-2027. doi: 10.1001/jama.2019.4492.

Specialty Drug Pricing and Out-of-Pocket Spending on Orally Administered Anticancer Drugs in Medicare Part D, 2010 to 2019.

Author information

1
Department of Health Policy, Vanderbilt University School of Medicine, Nashville, Tennessee.
2
Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts.
PMID:
31135837
PMCID:
PMC6547115
[Available on 2019-11-28]
DOI:
10.1001/jama.2019.4492
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center